Applied DNA Clinical Labs (ADCL), a subsidiary of Applied DNA Sciences, said this week that it has submitted a validation package to the New York State Department of Health (NYSDOH) to support the approval of a pharmacogenomics assay as a NYSDOH laboratory-developed test (LDT). If approved, the LDT test will be used by ADCL [...]
Applied DNA Sciences is very pleased to be a member of NCTO, an association dedicated to helping U.S. textile manufacturing and promoting products made in the United States. Applied DNA is a “Made in USA” solution provider, and is indeed the only U.S. provider of PCR-based DNA traceability solutions. All R&D and production is [...]
Ganesha Ecosphere Ltd., the largest recycled polyester (rPET) fiber producer in India with over 300-plus customers, 250-plus suppliers, and 500-plus product variants. The collaboration aims to provide brands and textile manufacturers with a trusted solution to support their sustainability goals for rPET and confirm raw material authenticity at all stages [...]
STONY BROOK, N.Y. – March 22, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (ADCL), has submitted a validation package to the New York State Department of Health (NYSDOH) in support of [...]
TÜV SÜD America Inc., a global leader in testing, inspection / audit and certification, announces a new collaboration with Applied DNA Sciences (ADNAS) to offer their scientific traceability services as a complement to TÜV SÜD’s product traceability solution. Applied DNA’s molecular DNA-based supply chain security and [...]
STONY BROOK, N.Y. – February 9, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the first quarter of fiscal 2023, ended December 31, 2022. “Applied DNA delivered a solid start to [...]
STONY BROOK, N.Y. – February 2, 2023 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in polymerase chain reaction ("PCR")-based technologies, today announced that it will release financial results for the three months ended December 31, 2022, after the market closes on Thursday, February 9, 2023. The Company will host a [...]
STONY BROOK, N.Y. – January 5, 2023 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced the publication of a peer-reviewed research article in Molecular Therapy – Methods & Clinical Development. The study, titled ‘A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits [...]
STONY BROOK, N.Y. - December 14, 2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced consolidated financial results for the fourth quarter and fiscal year ended September 30, 2022. “Applied DNA delivered four consecutive quarters of year-over-year revenue increases [...]